RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hyundai Bioscience Co Stock

Hyundai Bioscience Co Stocks 2024

Hyundai Bioscience Co Stocks

39.78 M

Ticker

048410.KQ

ISIN

KR7048410005

In 2024, Hyundai Bioscience Co had 39.78 M outstanding stocks, a 1.04% change from the 39.37 M stocks in the previous year.

The Hyundai Bioscience Co Stocks history

YEARNUMBER OF STOCKS (undefined KRW)
202339.78
202239.37
202136.92
202036
201935
201834
201733
201630
201530
201430
201323
201220
201111
201010
200910
200810
20073
2006-
2005-
2004-

Hyundai Bioscience Co shares outstanding

The number of shares was Hyundai Bioscience Co in 2023 — This indicates how many shares 39.776 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Hyundai Bioscience Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Hyundai Bioscience Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Hyundai Bioscience Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Hyundai Bioscience Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Hyundai Bioscience Co Aktienanalyse

What does Hyundai Bioscience Co do?

Hyundai Bioscience Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Hyundai Bioscience Co's Shares Outstanding

Hyundai Bioscience Co's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Hyundai Bioscience Co’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Hyundai Bioscience Co’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Hyundai Bioscience Co’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Hyundai Bioscience Co stock

How many stocks are there of Hyundai Bioscience Co?

The current number of stocks of Hyundai Bioscience Co is 39.78 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Hyundai Bioscience Co are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Hyundai Bioscience Co evolved in recent years?

The number of shares of Hyundai Bioscience Co has increased by 1.04% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Hyundai Bioscience Co as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Hyundai Bioscience Co?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Hyundai Bioscience Co pay?

Over the past 12 months, Hyundai Bioscience Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hyundai Bioscience Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of Hyundai Bioscience Co?

The current dividend yield of Hyundai Bioscience Co is .

When does Hyundai Bioscience Co pay dividends?

Hyundai Bioscience Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hyundai Bioscience Co?

Hyundai Bioscience Co paid dividends every year for the past 0 years.

What is the dividend of Hyundai Bioscience Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hyundai Bioscience Co located?

Hyundai Bioscience Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Hyundai Bioscience Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hyundai Bioscience Co from 4/13/2004 amounting to 50 KRW, you needed to have the stock in your portfolio before the ex-date on 12/29/2003.

When did Hyundai Bioscience Co pay the last dividend?

The last dividend was paid out on 4/13/2004.

What was the dividend of Hyundai Bioscience Co in the year 2023?

In the year 2023, Hyundai Bioscience Co distributed 0 KRW as dividends.

In which currency does Hyundai Bioscience Co pay out the dividend?

The dividends of Hyundai Bioscience Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hyundai Bioscience Co

Our stock analysis for Hyundai Bioscience Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hyundai Bioscience Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.